NCT02292797View on ClinicalTrials.gov

Assessment of the Rosacea Prevalence in the General Population

CompletedOBSERVATIONAL
Enrollment

6,000

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Rosacea
Interventions
OTHER

Prevalence assessment

Assessment of the prevalence of rosacea in the general population per country using subject questionnaire and dermatologist diagnosis

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY